843 related articles for article (PubMed ID: 2488233)
1. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
[TBL] [Abstract][Full Text] [Related]
3. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor genes.
Levine AJ
Bioessays; 1990 Feb; 12(2):60-6. PubMed ID: 2140509
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the E1a gene of type 5 adenovirus result in oncogenic transformation of Fischer rat embryo cells.
Duigou GJ; Babiss LE; Liaw WS; Zimmer SG; Ginsberg HS; Fisher PB
J Cell Biochem; 1987 Feb; 33(2):117-26. PubMed ID: 3571338
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization is essential for the activity of p53 protein.
Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
[TBL] [Abstract][Full Text] [Related]
7. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
8. Cellular proteins that are targetted by DNA tumor viruses for transformation.
Dyson N; Buchkovich K; Whyte P; Harlow E
Princess Takamatsu Symp; 1989; 20():191-8. PubMed ID: 2488232
[TBL] [Abstract][Full Text] [Related]
9. The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.
Yehiely F; Oren M
Cell Growth Differ; 1992 Nov; 3(11):803-9. PubMed ID: 1467307
[TBL] [Abstract][Full Text] [Related]
10. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
Chang F; Syrjänen S; Kurvinen K; Syrjänen K
Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
[TBL] [Abstract][Full Text] [Related]
11. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
Tarunina M; Grimaldi M; Ruaro E; Pavlenko M; Schneider C; Jenkins JR
Oncogene; 1996 Aug; 13(3):589-98. PubMed ID: 8760300
[TBL] [Abstract][Full Text] [Related]
12. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
Schmieg FI; Simmons DT
Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
[TBL] [Abstract][Full Text] [Related]
13. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
Yam JW; Zheng JY; Hsiao WL
Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
[TBL] [Abstract][Full Text] [Related]
15. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
16. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
17. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
[TBL] [Abstract][Full Text] [Related]
18. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
19. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
20. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
Hansen RS; Braithwaite AW
Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
